Chris Gropp | Clinical Trial Technology and the Future of Decentralized Research
Chris Gropp joins Executive Insights for Life Sciences Innovators to discuss clinical trial technology, decentralized research, AI in clinical operations, and the infrastructure challenges shaping modern clinical studies.
Prefer audio only? Listen to this episode on Spotify.
Episode Overview
In this episode, Chris Gropp discusses how Trialogics is developing integrated clinical trial technology platforms designed to improve how research data is captured, managed, and utilized across global studies. The conversation explores decentralized trials, operational inefficiencies in clinical research, AI in clinical operations, and the challenges of building scalable technology infrastructure in regulated environments.
Key Themes
- Clinical trial technology and integrated research platforms
- Decentralized clinical trials and remote patient data collection
- eConsent, IRT/IWRS, ePRO/eCOA, and device integration
- AI applications in clinical operations and study management
- Operational efficiency in clinical research infrastructure
- Scaling technology companies in regulated life sciences markets
Why This Matters for Life Sciences Leaders
As clinical research becomes increasingly decentralized and data-intensive, life sciences organizations are under growing pressure to improve operational efficiency, patient engagement, and real-time data visibility. The conversation highlights how integrated technology infrastructure may help reduce fragmentation across clinical studies while supporting better execution, scalability, and patient experience in modern research environments.
Guest Link
More from Executive Insights
Explore more conversations with life sciences founders, CEOs, investors, and operators on the Executive Insights for Life Sciences Innovators podcast.
